Malonyl-CoA Decarboxylase Deficiency
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Malonyl-CoA Decarboxylase Deficiency

What is the definition of Malonyl-CoA Decarboxylase Deficiency?

Malonyl-CoA decarboxylase deficiency is a condition that prevents the body from converting certain fats into energy.

What are the causes of Malonyl-CoA Decarboxylase Deficiency?

Genetic changes that cause disease are called pathogenic variants. Pathogenic variants in the MLYCD gene cause malonyl-CoA decarboxylase deficiency. The MLYCD gene provides instructions for making an enzyme called malonyl-CoA decarboxylase. Malonyl-CoA decarboxylase is responsible for the chemical reaction that converts a molecule called malonyl-CoA into a molecule called acetyl-CoA, which is then used to make new fatty acids. Many tissues, including the heart and brain, use fatty acids as a major source of energy. When malonyl-CoA decarboxylase is not active, malonyl-CoA stops other enzymes from breaking down fatty acids.

How prevalent is Malonyl-CoA Decarboxylase Deficiency?

Malonyl-CoA decarboxylase deficiency is very rare; only about 60 cases have been reported in the scientific literature.

Is Malonyl-CoA Decarboxylase Deficiency an inherited disorder?

Malonyl-CoA decarboxylase deficiency is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell must have a pathogenic variant to cause the disorder. The parents of an individual with an autosomal recessive condition each carry one copy of the altered gene, but they typically do not show signs and symptoms of the condition.

Who are the top Malonyl-CoA Decarboxylase Deficiency Local Doctors?
Experienced in Malonyl-CoA Decarboxylase Deficiency
Interventional Cardiology
Experienced in Malonyl-CoA Decarboxylase Deficiency
Interventional Cardiology
Referral may be required

Midwest Heart And Vascular Specialists - Independence

19550 E 39th St S Ste 215, 
Independence, MO 
Languages Spoken:
English, Spanish
Accepting New Patients

Paul Nager is an Interventional Cardiologist practicing medicine in Independence, Missouri. Dr. Nager is rated as an Experienced provider by MediFind in the treatment of Malonyl-CoA Decarboxylase Deficiency. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pediatric Myocarditis, Coronary Heart Disease, Atherosclerosis, Aortic Regurgitation, and Pacemaker Implantation. Dr. Nager is currently accepting new patients.

Experienced in Malonyl-CoA Decarboxylase Deficiency
Experienced in Malonyl-CoA Decarboxylase Deficiency
Referral may be required

Midwest Heart And Vascular Specialists - Lexington

1500 State St, 
Lexington, MO 
Languages Spoken:
English, Russian, Spanish
Accepting New Patients

Alan Schneider is a Cardiologist practicing medicine in Lexington, Missouri. Dr. Schneider is rated as an Experienced provider by MediFind in the treatment of Malonyl-CoA Decarboxylase Deficiency. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Pediatric Myocarditis, Aortic Regurgitation, Necrosis, and Atherosclerosis. Dr. Schneider is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Malonyl-CoA Decarboxylase Deficiency
Distinguished in Malonyl-CoA Decarboxylase Deficiency
Referral may be required
1665 KongJiang Road, 
Shanghai, CN 

Xuefan Gu practices practicing medicine in Shanghai, China. Gu is rated as a Distinguished expert by MediFind in the treatment of Malonyl-CoA Decarboxylase Deficiency. They are also highly rated in 27 other conditions, according to our data. Their clinical expertise encompasses Malonyl-CoA Decarboxylase Deficiency, Methylmalonic Acidemia, Multiple Carboxylase Deficiency, and Ornithine Transcarbamylase Deficiency.

What are the latest Malonyl-CoA Decarboxylase Deficiency Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: September 17, 2026
Published By: National Institutes of Health